Kidney Effects of Liraglutide

Liraglutide (marketed as Victoza or Saxenda) is a glucagon-like peptide -1 (GLP-1) receptor agonist that is dipeptidyl peptidase-4 (DPP-4) resistant. It is a once a day subcutaneous injection with doses ranging from 0.6mg to 1.8mg daily. It is…

LVAD for the Nephrologist-Part 1

Advanced heart failure is associated with very poor survival rates of about 10 % at one year. Treatment options include cardiac transplantation or cardiac assist devices. A left ventricular assist device (LVAD) is a mechanical circulatory support for…

6978 0
Load more